Metabolism and Cancer.

Authors

  • José Joaquín Serrano Spain

Keywords:

cancer, metabolism, tumorigenic transformation

Abstract

 The research perspective on cancer has long been based on the detection of those genes involved in tumorigenic transformation. It is true that the weight of these in the appearance of cancer cells is more than contrasted (Lane, 1992), but in recent times there have been numerous advances in understanding how the metabolism of cancer cells allows them to maintain a malignant phenotype, to the point of being recently designated as one of the new hallmarks of cancer (Hanahan and Weinberg, 2021).

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Gottlieb E, Tomlinson IP (2005). Mitochondrial tumor supressors: a genetic and biochemical update. Nature reviews cancer 5: 857-866.

Haigis MC, Sinclair DA (2010). Mammalian sirtuins: biological insights and disease relevance. Annual Review Pathology 5: 253-295.

Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell 144: 646-674

Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson CB (2005). ATP citrate lyase inhibition can suppress tumor cell growth. Cancer cell 8: 311-321.

Hsu P, Sabatini D (2008). Cancer cell metabolism: Warbug and Beyond. Cell 134: 703-708

Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E (2006). Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor associated stroma. Cancer research 66: 632-637.

Kroemer G, Pouyssegur J (2008). Tumor cell metabolism: Cancer´s achilles heel. Cancer cell 13: 472-482

Lane D (1992). p53, the guardian of genome. Nature 358: 6-15.

Mazurek S, Boschek CB, Hugo F, Eigenbrodt E (2005). Pyruvate Kinase type M2 and its role in tumor growth and spreading. Seminars cancer biology 15: 300-308.

Menendez JA, Lupu R (2007). Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nature Reviews Cancer 7: 763-777.

Pedersen PL (2007). Warbug, me and Hexokinase 2: Multiple discoveries of key molecular events underliying one of cancer´s most common phenotypes the “Warbug effect”. Journal Bioenergetics Biomembranes 39: 211-222.

Tisdale MJ (2002). Cachexia in cancer patients. Nature Reviews Cancer 2 862-871.

Trachooman D, Alexandre J, Huang P (2009). Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature Reviews Drug Discovery 8: 579-591.

Wang HQ, Altomare DA, Skele KL, Poulikakos PI, Kuhajda FP, Di Cristofano A, Testa JR (2005). Positive feedback regulation between AKT

activation and fatty acid synthase expression in ovarían carcinoma cells. Oncogene 24: 3574-3582.

Warbug O, Posener K, Negelein E (1924). Über den Stoffweschsel der tumoren. Biochemie Zentrum 152, 319-344.

Young CD, Anderson SM (2008). Sugar and fat - that’s where it’s at: metabolic changes in tumors. Breast Cancer Research 10: 202-211.

Published

2012-07-20

How to Cite

Joaquín Serrano, J. (2012). Metabolism and Cancer. Encuentros En La Biología, 5(138-139), 35–36. Retrieved from https://revistas.uma.es/index.php/enbio/article/view/18425